Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[White coat hypertension].

J Soma1, K J Dahl, T E Widerøe

  • 1Medisinsk avdeling Regionsykehuset i Trondheim.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|March 30, 1999
PubMed
Summary

White coat hypertension, high blood pressure only at the doctor's office, affects up to 30% of hypertensive patients. Ambulatory blood pressure monitoring helps assess risk in these individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an in vitro immunobiotic evaluation system against rotavirus infection in bovine intestinal epitheliocytes.

Beneficial microbes·2017
Same author

Systemic non-amyloidotic fibril deposition disease: a probable variant form of fibrillary glomerulonephritis.

Clinical nephrology·2010
Same author

Classic polyarteritis nodosa presenting with rapidly progressive renal insufficiency.

Clinical nephrology·2010
Same author

Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.

Clinical nephrology·2008
Same author

Tranilast: a novel weapon against insulin resistance.

Medical hypotheses·2005
Same author

Effect of sivelestat, an inhibitor of neutrophil elastase, on rapidly progressive glomerulonephritis.

Clinical nephrology·2003

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Physiology

Context:

  • White coat hypertension (WCH) is defined as elevated blood pressure in clinical settings with normal readings elsewhere.
  • WCH prevalence may reach 30% in hypertensive populations, posing diagnostic challenges.
  • The prognostic significance of WCH remains under investigation, prompting research into its characteristics.

Purpose:

  • To explore the definition and diagnostic utility of ambulatory blood pressure recordings in identifying WCH.
  • To investigate potential physiological characteristics of WCH, such as reduced vasodilator capacity and arterial compliance.
  • To assess the role of ambulatory blood pressure monitoring in the risk stratification of hypertensive individuals.

Summary:

  • Ambulatory blood pressure monitoring (ABPM) is increasingly used to differentiate true hypertension from WCH.
  • Evidence suggests WCH may be linked to impaired vasodilator function and reduced arterial compliance.
  • While WCH prognosis is not fully established, ABPM is crucial for accurate hypertension assessment.

Impact:

  • Improved diagnostic accuracy for hypertension, distinguishing WCH from sustained hypertension.
  • Enhanced risk stratification for patients with elevated blood pressure, potentially avoiding unnecessary treatment.
  • Further understanding of vascular mechanisms in WCH, contributing to personalized hypertension management.

Related Experiment Videos